United Kingdom (GB)

The EDELIFE clinical trial, the first investigation of a signalling molecule to treat in utero a human developmental genetic disorder (2024) Schneider H, Hadj-Rabia S, Faschingbauer F, Bodemer C, Grange DK, Guillén-Navarro E, Tadini G, Clarke A Journal article, Original article Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence (2024) Sharp AS, Cao KN, Esler MD, Kandzari DE, Lobo MD, Schmieder R, Pietzsch JB Journal article Cardiorenal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among people underrepresented in trials: Analysis of routinely collected data with emulation of a reference trial (ONTARGET) (2024) Baptiste PJ, Wong AY, Schultze A, Clase CM, Leyrat C, Williamson E, Powell E, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article Tuning the morphology and energy levels in organic solar cells with metal–organic framework nanosheets (2024) Sasitharan K, Frisch J, Kuliček J, Iraqi A, Lidzey DG, Bär M, Rezek B, Foster JA Journal article Early photometric and spectroscopic observations of the extraordinarily bright INTEGRAL-detected GRB 221009A (2024) Sánchez-Ramírez R, Guedes Lang R, Pozanenko A, Martínez-Huerta H, Hu YD, Pandey SB, Gupta R, et al. Journal article Unmet Needs in Spondyloarthritis: Pathogenesis, Clinical Trial Design, and Nonpharmacologic Therapy (2024) Coates LC, Schett G, Wang C, Weiss PF Journal article A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study (2024) Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, et al. Journal article Continuous-wave electrically pumped multi-quantum-well laser based on group-IV semiconductors (2024) Seidel L, Liu T, Concepción O, Marzban B, Kiyek V, Spirito D, Schwarz D, et al. Journal article Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article, Erratum